Detail page

Knowledge Web

Person

Gwendolyn Gramer (1979-)

Kinderärztin

Name	Gwendolyn Gramer
Time	1979- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Deutschland
Gender	weiblich
Academic degree	Dr. med. (an der Medizinischen Fakultät der Universität Würzburg) (2006)
Profession	Kinderärztin (characteristic profession)
Variant	Gwendolyn Christine Gramer Gwendolyn C. Gramer
Related	Klinikum Heidelberg
Further information	Fachärztin für Kinder- und Jugendmedizin; Funktionsoberärztin, Klinik Kinderheilkunde I, Zentrum für Kinder- und Jugendmedizin Heidelberg, Universitätsklinikum Heidelberg; Privatdozentin
Record type	Person
GND-Identifier	132278626
Record ID	132278626
Involved in show all Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples Long‐term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial Elternbefragung zum Neugeborenenscreening auf Mukoviszidose nach Einführung in das Regelscreening in Deutschland Vitamin B12 Deficiency in Newborns and their Mothers—Novel Approaches to Early Detection, Treatment and Prevention of a Global Health Issue Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis—implications for process quality and patient care Vitamin-B12-Mangel im Neugeborenen- und Säuglingsalter – Ursachen, Früherkennung, Diagnostik und Vorstellung eines primär oralen Behandlungsschemas Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation Citrin deficiency mimicking mitochondrial depletion syndrome Primary carnitine deficiency – diagnosis after heart transplantation: better late than never! High incidence of maternal vitamin B12 deficiency detected by newborn screening: first results from a study for the evaluation of 26 additional target disorders for the German newborn screening panel Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability Genetic cause and prevalence of hydroxyprolinemia Das erweiterte Neugeborenen-Screening Paranoid delusion as lead symptom in two siblings with late-onset Tay–Sachs disease and a novel mutation in the HEXA gene Das erweiterte Neugeborenenscreening : Erfolge und neue Herausforderungen Das erweiterte Neugeborenenscreening : Erfolge und neue Herausforderungen Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany * Familienanamnese, genetisches Risikoprofil und Risikofaktoren der Glaukome : eine Untersuchung von 2170 Patienten mit Glaukom oder okulärer Hypertension Familienanamnese, genetisches Risikoprofil und Risikofaktoren der Glaukome : eine Untersuchung von 2170 Patienten mit Glaukom oder okulärer Hypertension

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Gwendolyn Gramer (1979-)

Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias

Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples

Long‐term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening

Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial

Elternbefragung zum Neugeborenenscreening auf Mukoviszidose nach Einführung in das Regelscreening in Deutschland

Vitamin B12 Deficiency in Newborns and their Mothers—Novel Approaches to Early Detection, Treatment and Prevention of a Global Health Issue

Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis—implications for process quality and patient care

Vitamin-B12-Mangel im Neugeborenen- und Säuglingsalter – Ursachen, Früherkennung, Diagnostik und Vorstellung eines primär oralen Behandlungsschemas

Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation

Citrin deficiency mimicking mitochondrial depletion syndrome

Primary carnitine deficiency – diagnosis after heart transplantation: better late than never!

High incidence of maternal vitamin B12 deficiency detected by newborn screening: first results from a study for the evaluation of 26 additional target disorders for the German newborn screening panel

Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial

Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability

Genetic cause and prevalence of hydroxyprolinemia

Das erweiterte Neugeborenen-Screening

Paranoid delusion as lead symptom in two siblings with late-onset Tay–Sachs disease and a novel mutation in the HEXA gene

Das erweiterte Neugeborenenscreening : Erfolge und neue Herausforderungen

Das erweiterte Neugeborenenscreening : Erfolge und neue Herausforderungen

Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *

Familienanamnese, genetisches Risikoprofil und Risikofaktoren der Glaukome : eine Untersuchung von 2170 Patienten mit Glaukom oder okulärer Hypertension

Familienanamnese, genetisches Risikoprofil und Risikofaktoren der Glaukome : eine Untersuchung von 2170 Patienten mit Glaukom oder okulärer Hypertension